Evidence map›Paper›PMID 40385868›Full record

ArticleCureus2025

A Survey of Current Tobacco and Nicotine Product Users to Identify Barriers to Quitting Smoking in Germany.

Christoph Neubert, Nelson Tewes, Alexander K Nussbaum

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Christoph NeubertScientific and Medical Affairs, Philip Morris GmbH, Gräfelfing, DEU.
Nelson TewesScientific and Medical Affairs, Philip Morris GmbH, Gräfelfing, DEU.
Alexander K NussbaumScientific and Medical Affairs, Philip Morris GmbH, Gräfelfing, DEU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSmoking rates remain high in Germany despite the well-known serious health risks. This survey assessed motivation to stop smoking in Germany and barriers to quitting smoking or switching to two types of smoke-free products (SFPs): e-cigarettes (E-cigs) and heated tobacco products (HTPs).

methodsIn 2022, computer-assisted web interviews were conducted among adults (>19 years) who smoked (n=1,000) or used SFPs (n=196).

resultsOverall, 51.2% of people who smoke were not motivated to stop smoking, 29.1% reported an intention to quit in the following year, and the remainder had some desire to quit but had not decided when to try. Lack of motivation was highest among people who smoke aged >65 years (64.4%) and lowest among those aged 19-34 years (38.9%). People with lower socioeconomic status who smoked had less motivation to quit than those with a higher socioeconomic status. In the sample of people who smoke, the barriers to quitting smoking included enjoyment of smoking (50.1%), difficulty in changing habits (41.4%), and lack of discipline (31.2%), with key differences among age groups. Only 27.3% of people who smoke perceived E-cigs/HTPs to have lower health risks relative to cigarettes, versus 84.7% of SFP users. Among SFP users, 41.8% reported a period of dual use when switching away from cigarettes. For the vast majority (89.1%), this period lasted less than a year, and 96.3% reported reduced cigarette consumption during this phase.

conclusionsDespite the well-known health risks, a large number of people in Germany continue to smoke, with many not motivated to quit. The primary barrier to quitting is the enjoyment of smoking. Additionally, there are misperceptions about the relative risks of cigarettes versus SFPs among people who smoke. To effectively reduce smoking prevalence, targeted campaigns must address these barriers and correct these misperceptions. Existing tobacco control strategies should be supplemented with tobacco harm reduction approaches to drive down smoking prevalence as quickly as possible.

Indexed as

barriers to quitting smokinge-cigarettesheated tobacco productssmoke-free productssmokingtobaccotobacco harm reduction

Identifiers

PMID40385868
PMCPMC12084851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.